974P First-in-human phase I dose finding study of INCB123667, a selective CDK2 inhibitor, in patients with advanced solid tumors.
Saved in:
| Title: | 974P First-in-human phase I dose finding study of INCB123667, a selective CDK2 inhibitor, in patients with advanced solid tumors. |
|---|---|
| Authors: | Lorusso, D.1 (AUTHOR), Simonelli, M.2 (AUTHOR), Homicsko, K.3 (AUTHOR), Colombo, I.4 (AUTHOR), Kitano, S.5 (AUTHOR), Cassier, P.6 (AUTHOR), Robbrecht, D.G.7 (AUTHOR), Italiano, A.8 (AUTHOR), Pinato, D.J.9 (AUTHOR), Hasegawa, K.10 (AUTHOR), Bahleda, R.11 (AUTHOR), Wang, E.12 (AUTHOR), Abbas, R.13 (AUTHOR), van der Velden, M.14 (AUTHOR), Liu, Q.15 (AUTHOR), Croft, E.16 (AUTHOR), Damian, S.17 (AUTHOR) |
| Source: | Annals of Oncology. 2025 Supplement 2, Vol. 36, pS637-S638. 2p. |
| Database: | Academic Search Ultimate |
| ISSN: | 09237534 |
|---|---|
| DOI: | 10.1016/j.annonc.2025.08.1543 |
